Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIPEL.L Regulatory News (IPEL)

  • There is currently no data for IPEL

Form 8 (OPD) - Impellam Group plc

27 Apr 2022 15:15

RNS Number : 5773J
Impellam Group plc
27 April 2022
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Impellam Group plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Impellam Group plc

(d) Is the discloser the offeror or the offeree?

OFFEREE

(e) Date position held:

The latest practicable date prior to the disclosure

26 April 2022

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

Ordinary shares of 1 pence each

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

-

Nil

-

(2) Cash-settled derivatives:

 

Nil

-

Nil

-

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

-

Nil

-

 

TOTAL:

Nil

-

Nil

-

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

None

Details, including nature of the rights concerned and relevant percentages:

N/A

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

(a) Interests in Impellam Group plc ordinary shares held by directors of Impellam Group plc and their close relatives and related trusts

 

Director

Number of ordinary Impellam Group plc shares of 1 pence each

Percentage of total issued share capital (%)

Lord Ashcroft (1)

28,019,055

62.05

Julia Robertson

153,910

0.34

Mike Ettling

10,860

0.02

Angela Entwistle

13,800

0.03

 

(1) 25,745,300 ordinary shares held by Lombard Trust and the remainder by Lord Ashcroft.

 

(b) Interests in Impellam Group plc ordinary shares held by an employee benefit trust of Impellam Group plc

 

Entity

Number of ordinary Impellam Group plc shares of 1 pence each

Percentage of total issued share capital (%)

Spread Trustee Company Ltd as trustee of the Impellam Group plc employee benefit trust

19,800

0.04

 

 

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

27 April 2022

Contact name:

Julia Robertson

Telephone number:

Tel: +44 (0) 20 3096 4790

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEEUBRSRUVUSUAR
Date   Source Headline
9th Jan 202310:44 amRNSForm 8.5 (EPT/RI)
9th Jan 202310:31 amRNSRule 2.9 Announcement
9th Jan 202310:30 amRNSTransaction in Own Shares
6th Jan 202312:04 pmRNSForm 8.3 - Impellam Group PLC
6th Jan 202310:30 amRNSForm 8.5 (EPT/RI)
5th Jan 20232:33 pmRNSForm 8.3 - Impellam Group PLC
5th Jan 20239:16 amRNSForm 8.5 (EPT/RI) - Impellam Group plc
4th Jan 20231:31 pmRNSForm 8.3 - Impellam Group PLC
4th Jan 20238:22 amRNSForm 8.5 (EPT/RI)
3rd Jan 20237:00 amRNSForm 8.3 - Impellam Group Plc
30th Dec 202210:01 amRNSForm 8.3 - Impellam Group PLC
29th Dec 202211:10 amRNSForm 8.5 (EPT/RI) - Impellam Group plc
29th Dec 20229:53 amRNSForm 8.3 - Impellam Group PLC
28th Dec 202210:51 amRNSForm 8.5 (EPT/RI)
23rd Dec 20229:37 amRNSForm 8.5 (EPT/RI)
22nd Dec 20227:00 amRNSSpecial Dividend Declaration
14th Dec 20222:55 pmRNSRule 2.9 Announcement
14th Dec 20222:30 pmRNSTransaction in Own Shares
14th Dec 20227:28 amRNSForm 8.5 (EPT/RI)
12th Dec 202210:00 amRNSRule 2.9 Announcement
12th Dec 202210:00 amRNSTransaction in Own Shares
12th Dec 20227:48 amRNSForm 8.5 (EPT/RI)
9th Dec 202211:03 amRNSForm 8.5 (EPT/RI)
8th Dec 202211:25 amRNSForm 8.5 (EPT/RI) - Impellam Group plc
6th Dec 20229:51 amRNSForm 8.5 (EPT/RI)
6th Dec 20227:00 amRNSRule 2.9 Announcement
6th Dec 20227:00 amRNSTransaction in Own Shares
2nd Dec 20224:02 pmRNSRule 2.9 Announcement
2nd Dec 20224:01 pmRNSTransaction in Own Shares
2nd Dec 20227:00 amRNSForm 8.5 (EPT/RI)
1st Dec 202212:01 pmRNSRule 2.9 Announcement
1st Dec 202212:00 pmRNSTransaction in Own Shares
1st Dec 202210:02 amRNSForm 8.5 (EPT/RI)
30th Nov 20227:31 amRNSForm 8.5 (EPT/RI)
30th Nov 20227:01 amRNSRule 2.9 Announcement
30th Nov 20227:00 amRNSTransaction in Own Shares
29th Nov 20227:00 amRNSForm 8.5 (EPT/RI)
28th Nov 202211:01 amRNSForm 8.5 (EPT/RI)
28th Nov 20229:00 amRNSRule 2.9 Announcement
28th Nov 20229:00 amRNSTransaction in Own Shares
25th Nov 20229:05 amRNSForm 8.5 (EPT/RI)
23rd Nov 202210:46 amRNSRule 2.9 Announcement
23rd Nov 202210:45 amRNSTransaction in Own Shares
23rd Nov 202210:13 amRNSForm 8.5 (EPT/RI)
22nd Nov 20229:16 amRNSRule 2.9 Announcement
22nd Nov 20229:15 amRNSTransaction in Own Shares
22nd Nov 20228:03 amRNSForm 8.5 (EPT/RI)
21st Nov 202210:45 amRNSForm 8.5 (EPT/RI)
21st Nov 20227:01 amRNSRule 2.9 Announcement
21st Nov 20227:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.